Comment on "The safety and cost of Gelofusine as a replacement fluid in therapeutic plasma exchange procedures-feedback from low/ middle-income countries"

Akshaya Tomar

Open source

DOI
10.1016/j.transci.2026.104537
Published
2026-12
Container
Transfusion and Apheresis Science
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.transci.2026.104537,
  title = {Comment on "The safety and cost of Gelofusine as a replacement fluid in therapeutic plasma exchange procedures-feedback from low/ middle-income countries"},
  author = {Akshaya Tomar},
  year = {2026},
  journal = {Transfusion and Apheresis Science},
  doi = {10.1016/j.transci.2026.104537},
  url = {https://doi.org/10.1016/j.transci.2026.104537}
}

RIS

TY  - JOUR
TI  - Comment on "The safety and cost of Gelofusine as a replacement fluid in therapeutic plasma exchange procedures-feedback from low/ middle-income countries"
AU  - Akshaya Tomar
PY  - 2026
JO  - Transfusion and Apheresis Science
DO  - 10.1016/j.transci.2026.104537
UR  - https://doi.org/10.1016/j.transci.2026.104537
ER  - 

APA

Tomar, A. (2026). Comment on "The safety and cost of Gelofusine as a replacement fluid in therapeutic plasma exchange procedures-feedback from low/ middle-income countries". Transfusion and Apheresis Science. https://doi.org/10.1016/j.transci.2026.104537

Source records